1 Maisel AS, Krishnaswamy P, Nowak R, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002 ; 347 : 161-7.
2 Pratter MR, Curley FJ, Dubois J, Irwin RS. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med 1989 ; 149 : 2277-82.
Zoorob RJ, Cambell JS. Acute dyspnea in the office. Am Fam Physician 2003 ; 68 : 1803-10.
3 Reddel HK, Marks GB, Jenkins CR. When can personal best peak flow be determined for asthma action plans ? Thorax 2004 ; 59 : 922-4.
4 American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995 ; 152 : 1107-36.
5 Dekker FW, Schrier AC, Sterk PJ, Dijkman JH. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax 1992 ; 47 : 162-6.
Boezen HM, Schouten JP, Postma DS, Rijcken B. Distribution of peak expiratory flow variability by age, gender and smoking habits in a random population sample aged 20-70 yrs. Eur Respir J 1994 ; 7 : 1814-20.
6 Wang CS, Fitzgerald MB, Schulzer M, et al. Does This Dyspneic Patient in the Emergency Department Have Congestive Heart Failure ? JAMA 2005 ; 294 : 1944-56.
7 Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004 ; 350 : 647-54.
8 Maisel AS, Krishnaswamy P, Nowak R, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002 ; 347 : 161-7.
9 Baggish AL,Siebert U,Lainchbury JG, et al. A validated clinical and biochemical score for the diagnosis of acute heart failure : The ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. Am Heart J 2006 ; 151 : 48-54.
10 Francesca Bursi F, Weston SA, Redfield M, et al. Systolic and Diastolic Heart Failure in the Community. JAMA 2006 ; 296 : 2209-16.
11 Enright PL, Sherill DL, Lebowitz MD. Ambulatory monitoring of peak expiratory flow. Reproductibility and quality control. Chest 1995 ; 107 : 657.
Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of Diurnal Changes in Peak Expiratory Flow Rates : Am Rev Resp Dis 1991 ; 143 : 323-30.
12 Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991 ; 325 : 388-92.
13 Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997 ; 277 : 887-91.
14 Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996 ; 153 : 1481-8.
Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O’Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. New Engl J Med 1997 ; 337 : 1405-11.
15 O’Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005 ; 171 : 129-36.
16 Creticos P, Burk J, Smith L, Comp R, Norman P, Findlay S. The use of twice daily nedocromil sodium in the treatment of asthma. J Allergy Clin Immunol 1995 ; 95 : 829-36.
17 Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, Rickard KA. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. J Allergy Clin Immunol 2000 ; 105 : 1123-9.
18 Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, Zhang J, Reiss TF. Montelukast added to inhaled beclometasone in treatment of asthma. Montelukast/Beclometasone Additivity Group. Am J Respir Crit Care Med 1999 ; 160 : 1862-8.
19 Löfdahl CG, Reiss TF, Leff JA, Israel E, Noonan MJ, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ 1999 ; 319 : 87-90.
20 Jean Bousquet; Sally Wenzel; Stephen Holgate, et al. Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma. Chest 2004 ; 125 : 1378-86.
21 Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database of Systematic Reviews. Issue 1, 2003.
22 Aaron SD, Dales RE, Pham B. Management of steroiddependent asthma with methotrexate : A meta-analysis of randomized clinical trials. Respir Med 1998 ; 92 : 1059-65.
23 Ram FSF, Robinson SM, Black PN. Physical training for asthma. Cochrane Database of Systematic Reviews. Issue 2, 2000.
24 Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database of Systematic Reviews. Issue 2, 2000.
25 Adkinson NF Jr, Eggleston PA, Eney D, Goldstein EO, Schuberth KC, Bacon JR, Hamilton RG, Weiss ME, Arshad H, Meinert CL, Tonascia J, Wheeler B. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 1997 ; 336, 1010-5.
26 Gøtzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane Database of Systematic Reviews. Issue 4, 2004.
27 Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy : A systematic review and meta-analysis. Arch Intern Med 1999 ; 10 ; 159 : 941-55.
Garbe E, Suissa S, Le Lorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998 ; 280 : 539-43.
28 Satpathy C, Mishra TK, Satpathy R, Satpathy HK, Barone E. Diagnosis and management of diastolic dysfunction and heart failure. Am Fam Physician 2006 ; 73 : 841-6.
29 Bukharovich IF, Kukin M. Optimal therapy for heart failure. Prog in Cardiovasc Dis 2006 ; 48 : 372-85.
Hunt SA, Baker DW, Chin MH. ACC/AHA guidelines for the evaluation and management of heart failure in the adult. Accessible à l’adresse : http ://
www.acc.org (accès septembre 2006, mise à jour novembre 2005).
30 Young JB, Gheorghiade M, Uretsky BF, Patterson JH, Adams KF Jr. Superiority of «triple» drug therapy in heart failure : Insights from the PROVED and RADIANCE trials. Prospective randomized study of ventricular function and efficacy of digoxin. Randomized assessment of digoxin and inhibitors of angiotensin-converting enzyme. J Am Coll Cardiol 1998 ; 32 : 686-92.
31 The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991 ; 325 : 293-302.
The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987 ; 316 : 1429-35.
32 Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996 ; 334 : 1349-55.
33 The CIBIS-II Investigators. The cardiac insufficiency bisoprolol study II (CIBIS-II) : A randomized trial. Lancet 1999 ; 353 : 9-13.
Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations and well-being in patients with heart failure : the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). JAMA 200 ; 283 : 1295-302.
34 Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999 ; 341 : 709-17.
35 The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 ; 336 : 525-33.
36 Vazquez de Prada JA, Ruano J, Martin-Duran R, Larman M, Zueco J, Ortiz de Murua JA, Torres A, Figueroa A. Noninvasive determination of pulmonary arterial systolic pressure by continuous wave Doppler. Int J Cardiol 1987 ; 16 : 177-84.
37 Wasserman K, Hansen JH, Sue DY. Principles of Exercise Testing and Interpretation. B.J. Whipp. Lea & Febiger, Philadelphia, 1987.
38 Righini M, Aujesky D, Roy PM, et al. Clinical usefulness of D-dimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism. Arch Intern Med 2004 ; 164 : 2483-7.
39 Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A. Prediction of pulmonary embolism in the emergency department : The revised Geneva score. Ann Intern Med 2006 ; 144 : 165-71.
40 Perrier A, Desmarais S, Goehring C, de Moerloose P, Morabia A, Unger PF, Slosman D, Junod A, Bounameaux H. D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med 1997 ; 156 : 492-6.
41 Lensing AW, Prandoni P, Brandjes D, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989 ; 320 : 342-5.
Cogo A, Lensing AWA, Koopman MMW, et al. Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis : Prospective cohort study. BMJ 1998 ; 316 : 17-20.
42 Bounameaux H, de Moerloose P, Perrier A, Miron MJ. D-dimer testing in suspected venous thromboembolism : An update. Q J Med 1997 ; 90 : 437-42.
43 Perrier A, Roy P-M, Sanchez O, LeGal G, Meyer G, Gourdier A-L, Revel M-P, Howarth N, Davido A, Bounameaux H. Multidetector-row computed tomography in suspected pulmonary embolism. NEJM 2005 ; 352 : 1760-8.
Van Belle A, Buller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006 ; 295 : 172-9.
44 Lensing AW, Prandoni P, Brandjes D, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989 ; 320 : 342-5.
Cogo A, Lensing AWA, Koopman MMW, et al. Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis : Prospective cohort study. BMJ 1998 ; 316 : 17-20.
45 Bounameaux H, de Moerloose P, Perrier A, Miron MJ. D-dimer testing in suspected venous thromboembolism : An update. Q J Med 1997 ; 90 : 437-42.
46 Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. NEJM 2006 ; 354 : 2317-27.
47 Perrier A, Bounameaux H. Accuracy or outcome in suspected pulmonary embolism. NEJM 2006 ; 354 : 2383-5.
48 Kluetz PG, White CS. Acute pulmonary embolism : Imaging in the emergency department. Radiol Clin North Am 2006 ; 44 : 259-71.
49 Harvey J, Prescott RJ. Simple aspiration versus intercostal tube drainage for spontaneous pneumothorax in patients with normal lungs. BMJ 1994 ; 309 : 1338-9.
50 Elfeldt RJ, Schroder DW, Thies J. Long-term follow-up of different therapy procedures in spontaneous pneumothorax. J Cardiovasc Surg (Torino) 1994 ; 35 : 229-33.
51 Yam LT. Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med 1967 ; 66 : 972-82.
52 Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005 ; 26 : 948-68.
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J spir Crit Care Med 1995 ; 152 : 1107-36.
Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993 ; 16 : 1-100.
53 Jones AP, Rowe BH. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database of Systematic Reviews. Issue 2, 2000.
